Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
British Journal of Clinical Pharmacology
|
June 25, 2010
Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects
Mohi Iqbal Mohammed Abdul, Xuemin Jiang, Kenneth M Williams, et al.
Drug Safety
|
July 23, 2013
Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012
Sheena N Ramasamy, Cameron S Korb-Wells, Diluk R W Kannangara, et al.
British Journal of Clinical Pharmacology
|
April 19, 2017
Individualising the dose of allopurinol in patients with gout
Diluk R W Kannangara, Garry G Graham, Daniel F B Wright, et al.
Alimentary Pharmacology & Therapeutics
|
January 22, 2020
The safety and pharmacokinetics of metformin in patients with chronic liver disease
Felicity C Smith, Sophie L Stocker, Mark Danta, et al.
British Journal of Clinical Pharmacology
|
September 1, 2019
Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis
Christina Abdel Shaheed, Jane E Carland, Garry G Graham, et al.
Clinical Pharmacokinetics
|
March 12, 2013
Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function
Janna K Duong, Shaun S Kumar, Carl M Kirkpatrick, et al.
British Journal of Clinical Pharmacology
|
March 26, 2021
Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices
Jane E Carland, Sophie L Stocker, Melissa T Baysari, et al.
Clinical Pharmacokinetics
|
January 19, 2011
Clinical pharmacokinetics of metformin
Garry G Graham, Jeroen Punt, Manit Arora, et al.
HIV Clinical Trials
|
April 30, 2004
A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals
Sarah L Pett, Lisa A Williams, Richard O Day, et al.
Arthritis Research & Therapy
|
October 15, 2015
Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout
Cushla McKinney, Lisa K Stamp, Nicola Dalbeth, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
British Journal of Clinical Pharmacology
|
June 25, 2010
Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects
Mohi Iqbal Mohammed Abdul, Xuemin Jiang, Kenneth M Williams, et al.
Drug Safety
|
July 23, 2013
Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012
Sheena N Ramasamy, Cameron S Korb-Wells, Diluk R W Kannangara, et al.
British Journal of Clinical Pharmacology
|
April 19, 2017
Individualising the dose of allopurinol in patients with gout
Diluk R W Kannangara, Garry G Graham, Daniel F B Wright, et al.
Alimentary Pharmacology & Therapeutics
|
January 22, 2020
The safety and pharmacokinetics of metformin in patients with chronic liver disease
Felicity C Smith, Sophie L Stocker, Mark Danta, et al.
British Journal of Clinical Pharmacology
|
September 1, 2019
Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis
Christina Abdel Shaheed, Jane E Carland, Garry G Graham, et al.
Clinical Pharmacokinetics
|
March 12, 2013
Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function
Janna K Duong, Shaun S Kumar, Carl M Kirkpatrick, et al.
British Journal of Clinical Pharmacology
|
March 26, 2021
Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices
Jane E Carland, Sophie L Stocker, Melissa T Baysari, et al.
Clinical Pharmacokinetics
|
January 19, 2011
Clinical pharmacokinetics of metformin
Garry G Graham, Jeroen Punt, Manit Arora, et al.
HIV Clinical Trials
|
April 30, 2004
A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals
Sarah L Pett, Lisa A Williams, Richard O Day, et al.
Arthritis Research & Therapy
|
October 15, 2015
Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout
Cushla McKinney, Lisa K Stamp, Nicola Dalbeth, et al.
Page
of 7